Objectives: Biliary atresia (BA) occurs in 0.54 of 10.000 of overall live births in the Netherlands. BAhas an unfavorable prognosis: Methods: Retrospective study including Dutch preterm infants treated for BA. Parameters included gestational age, congenital anomalies, age at KPE, days between first symptoms, and KPE and referral interval (first hospital to KPE). Outcome parameters were clearance of jaundice (COJ) and (transplant-free) survival. Data are presented as medians (ranges). Results: Included 28 preterm infants (13 boys/15 girls) between March 1988 and December 2015. The incidence of BA was 1.06 of 10.000 preterm live births. Gestational age was 34.8 (27.3-36.9) weeks. Congenital anomalies were present in 11 of 28 (39%) infants. Ti...
OBJECTIVES: To determine the epidemiology of biliary atresia (BA) in Switzerland, the outcome of the...
Aim:To estimate the incidence of Biliary Atresia(BA) amongst Neonatal Cholestatic Syndromes (NCS) an...
Background: Outcomes in biliary atresia (BA) have been well-documented in large national cohorts fro...
Objectives: Biliary atresia (BA) occurs in 0.54 of 10.000 of overall live births in the Netherlands....
Objectives: Biliary atresia (BA) occurs in 0.54 of 10.000 of overall live births in the Netherlands....
OBJECTIVE: To examine the outcome of biliary atresia (BA) and to identify prognostic factors using ...
OBJECTIVE: To examine the outcome of biliary atresia (BA) and to identify prognostic factors using a...
Objective To examine the outcome of biliary atresia (BA) and to identify prognostic factors using a ...
Objectives To investigate the characteristics of biliary atresia (BA) in preterm infants. Study des...
Objective To examine the outcome of biliary atresia (BA) and to identify prognostic factors using a ...
OBJECTIVES: To determine the prognosis of patients with biliary atresia (BA) after two years of nati...
OBJECTIVES: To determine the prognosis of patients with biliary atresia (BA) after two years of nati...
OBJECTIVES: To determine the epidemiology of biliary atresia (BA) in Switzerland, the outcome of the...
OBJECTIVES: To determine the epidemiology of biliary atresia (BA) in Switzerland, the outcome of the...
OBJECTIVES: To determine the epidemiology of biliary atresia (BA) in Switzerland, the outcome of the...
Aim:To estimate the incidence of Biliary Atresia(BA) amongst Neonatal Cholestatic Syndromes (NCS) an...
Background: Outcomes in biliary atresia (BA) have been well-documented in large national cohorts fro...
Objectives: Biliary atresia (BA) occurs in 0.54 of 10.000 of overall live births in the Netherlands....
Objectives: Biliary atresia (BA) occurs in 0.54 of 10.000 of overall live births in the Netherlands....
OBJECTIVE: To examine the outcome of biliary atresia (BA) and to identify prognostic factors using ...
OBJECTIVE: To examine the outcome of biliary atresia (BA) and to identify prognostic factors using a...
Objective To examine the outcome of biliary atresia (BA) and to identify prognostic factors using a ...
Objectives To investigate the characteristics of biliary atresia (BA) in preterm infants. Study des...
Objective To examine the outcome of biliary atresia (BA) and to identify prognostic factors using a ...
OBJECTIVES: To determine the prognosis of patients with biliary atresia (BA) after two years of nati...
OBJECTIVES: To determine the prognosis of patients with biliary atresia (BA) after two years of nati...
OBJECTIVES: To determine the epidemiology of biliary atresia (BA) in Switzerland, the outcome of the...
OBJECTIVES: To determine the epidemiology of biliary atresia (BA) in Switzerland, the outcome of the...
OBJECTIVES: To determine the epidemiology of biliary atresia (BA) in Switzerland, the outcome of the...
Aim:To estimate the incidence of Biliary Atresia(BA) amongst Neonatal Cholestatic Syndromes (NCS) an...
Background: Outcomes in biliary atresia (BA) have been well-documented in large national cohorts fro...